ASHPOfficial

This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce, and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.    

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.